WEIGHT LOSS Clinic
US$ 27.33
glp-1 agonists weight loss drugs market Analogues Size, Share & Growth Drivers By 2034 Glucagon-Like Peptide (GLP)-1 Agonists Weight
Description
Tirzepatides Dual GIP and GLP-1 Action Tirzepatide works through both GLP-1 and GIP pathways
It has been shown that an increased percentage of fat, adipose tissue dysfunction, and IR lead to increased levels of FFAs and carbohydrates
What was once a relatively small class of drugs has become one of the most significant drivers of pharmacy spend, transforming diabetes care and offering new treatment options to help address obesity
Nauck M, Rizzo M, Johnson A, BoschTraberg H, Madsen J, Cariou B
Unclear fee structures
